James Logan speaks to The Times (£) about a recent rise in the number of Lyme disease cases: “The cause is likely to be a number of factors […] there is also an increased awareness of the disease which means that we could just be seeing more of it because it is being diagnosed more.” James is also interviewed for BBC Two’s Trust Me I’m a Vet (from 15m20s) on the best way to tackle fleas.
Ngozi Erondu writes for The Conversation on the need for African governments to collaborate to secure a lower cost vaccine for meningitis: “[African governments] need to start funding and developing sufficient amounts of vaccines instead of bartering with large-scale pharmaceutical companies.”
John Edmunds provides comment to Reuters on the importance of having more than one type of Ebola vaccine, following a World Health Organization event held in Guinea: “It will not only change the way that we control future Ebola outbreaks, but has shown how we might go about developing vaccines for similar epidemic-prone diseases.”
Liam Smeeth provides comment for The Guardian about a study that suggests that the common side effects of statins are not down to the drugs but a result of patients’ negative expectations. On the warnings about side effects listed by the Medicines and Healthcare Products Regulatory Agency, Liam says: “I do think the MHRA advice could be toned down.”
There is further coverage of the WOMAN Trial results including articles in the Dhaka Tribune, Daily Star and News Hour (all Bangladesh), Business Insider, 20minutes (France), Global Citizen and Eastern Eye.
There is also continued coverage of Ajay Aggarwal’s study which found that the Cancer Drugs Fund failed to deliver meaningful value to patients and society, including the Financial Times (£).
Martin McKee and Lucinda Hiam are interviewed by News-Medical on their recent study that suggested an increase in mortality in England and Wales could be linked to failures in health and social care. Martin also writes for BMJ blogs on the importance of health in UK-EU discussions.